Global Blood Screening Market : Key Trends and Forecast Research Report 2022 to 2028


Posted January 11, 2024 by MarketResearchStudy

The Infinium Global Research analyses the Blood Screening Market over the period of 2022 to 2028.

 
The Infinium Global Research analyses the Blood Screening Market over the period of 2022 to 2028. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global food supply for restaurants market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of food supply for restaurants. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the food supply for restaurants market during the period.

To Know More Request a Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/42562

A groundbreaking development in immunoassay technology is set to revolutionize blood transfusion processes and enhance disease detection on a global scale. The demand for donated blood is on the rise, driven by the increasing need for complex surgical treatments, including cardiovascular and transplant surgery, trauma care, and therapy for cancer and blood-related illnesses.

Globally, an average of 235 million major surgeries are performed each year, with 63 million dedicated to trauma, over 31 million to cancer, and 10 million to pregnancy-related complications. Blood transfusions play a crucial role in preparing for various medical scenarios, such as trauma, congenital maternal blood abnormalities in children, acute anemia, and complications during labor and delivery.

The spotlight is on digital immunoassays, utilizing a grid of femtoliter-sized wells in Enzyme-Linked Immunosorbent Assay (ELISA). These assays offer a one-stop solution for single-molecule detection without the need for washing procedures. The process involves seeding a biomarker molecule, conjugated and amplified through an enzyme process, in a well alongside an antibody-coated magnetic microparticle. This innovative technology has garnered attention for its potential in developing serological COVID-19 antibody tests that are inexpensive, rapid, simple, highly sensitive, quantitative, and minimally invasive.

Enquire Here Get Customization and Check a Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/42562

Table Of Contents

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Blood Screening Market Highlights

2.2. Blood Screening Market Projection

2.3. Blood Screening Market Regional Highlights

Chapter 3. Global Blood Screening Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Analysis of COVID-19 impact on the Blood Screening Market

3.4. Porter's Five Forces Analysis

3.5. IGR-Growth Matrix Analysis

3.5.1. IGR-Growth Matrix Analysis by Product Type

3.5.2. IGR-Growth Matrix Analysis by Technology

3.5.3. IGR-Growth Matrix Analysis by End-user

3.5.4. IGR-Growth Matrix Analysis by Region

3.6. Value Chain Analysis of the Blood Screening Market

Chapter 4. Blood Screening Market Macro Indicator Analysis

Chapter 5. Global Blood Screening Market by Product Type

5.1. Reagents & Kits

5.2. Instruments

5.3. Software & Services

Chapter 6. Global Blood Screening Market by Technology

6.1. Nucleic Acid Amplification

6.2. ELISA

6.3. Rapid Tests

6.4. NGS

6.5. Western Blot Assay

Chapter 7. Global Blood Screening Market by End-user

7.1. Blood Banks

7.2. Hospitals

Chapter 8. Global Blood Screening Market by Region 2022-2028

8.1. North America

8.2. Europe

8.3. Asia-Pacific

8.4. RoW

Chapter 9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Blood Screening Market

9.2. Companies Profiles

9.2.1. Bio-Rad Laboratories, Inc.

9.2.2. Grifols, S.A.

9.2.3. F. Hoffmann-La Roche

9.2.4. Ortho Clinical Diagnostics

9.2.5. BD DiaSorin S.p.A.

9.2.6. Thermo Fisher Scientific Inc.

9.2.7. Abbott Laboratories

9.2.8. QUOTIENT Technology

9.2.9. Immucor.

9.2.10. Hologic Inc

For More Insights on this report, Speak to Our Analyst @ https://www.infiniumglobalresearch.com/reports/enquiry/42562

About Us

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling the business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients in improveing their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts is engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meetings with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the business environment's progress to offer our clients the best opinion.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By shubham
Phone 08999930634
Business Address Flat No. B/703, S. No. 22,
Hissa No. 10, Vastu River Nest,
Country India
Categories Business
Tags global blood screening market , market size , market share , market trends , market analysis , industry survey , top major key player , market demand
Last Updated January 11, 2024